Ventus Therapeutics US Inc. has divulged NLRP3 inflammasome inhibitors reported to be useful for the treatment of cancer, metabolic diseases, autoimmune diseases, and liver, renal, respiratory, ...

In a paper titled "Arachidonic acid inhibition of the NLRP3 inflammasome is a mechanism to explain the anti-inflammatory effects of fasting," published in Cell Reports, the team describes how fasting ...

Fructose, the most common food sweetener, is widely used in processed sugary beverages, candies, and baked goods. Excessive ...

Cerevance has announced positive outcomes from its Phase I trial of CVN293, a drug candidate designed to treat ...

Results showed that restricting calorie intake increased the lipid known as arachidonic acid, which reduced the activity of the NLRP3 inflammasome. And, as soon as members of the group ate a meal ...

We are pleased to announce the progress that ZyVersa has made toward achieving our key near-term development milestones,” stated ...

highlights data from an article published in the peer-reviewed International Journal of Nanomedicine titled Small Intestinal Endocrine Cell Derived Exosomal ACE2 Protects Islet beta-Cell Function by ...